• Combined Therapeutics Wins $250,000 MilliporeSigma Advance Biotech Grant

    1 month ago - By Xconomy

    MilliporeSigma has awarded MIT spin-out Combined Therapeutics a check for $250,000 as the winner of its 2020 Advance Biotech Grant. Combined Therapeutics is an early stage startup developing next generation virotherapy targeted with nucleic acids. The pre-clinical biotech aims to develop therapies to treat liver cancer using its targeted oncolytic platform. The firm-founded by MIT professors Robert Langer and Dan Anderson, along with entrepreneur Romain Micol-was the prestigious winner Thursday of the MilliporeSigma Advance Biotech Grant, part of the 2020 National Xconomy Awards event. The...
    Read more ...